Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection

NCT03794258 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Can not recruit the patients due to the pandemic of COVID-19

Conditions

HCV Infection

Interventions

DRUG: SOF+DCV+CDI-31244
DRUG: SOF+DCV+CDI-31244+ASV

Sponsor

Humanity & Health Medical Group Limited